Global Ophthalmic Drug Delivery Device Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Ophthalmic Drug Delivery Device market size was valued at US$ million in 2023. With growing demand in downstream market, the Ophthalmic Drug Delivery Device is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Ophthalmic Drug Delivery Device market. Ophthalmic Drug Delivery Device are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ophthalmic Drug Delivery Device. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ophthalmic Drug Delivery Device market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Ophthalmic Drug Delivery Device market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ophthalmic Drug Delivery Device market. It may include historical data, market segmentation by Type (e.g., Pre-Filled Syringes, Multidose Eyedroppers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ophthalmic Drug Delivery Device market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ophthalmic Drug Delivery Device market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ophthalmic Drug Delivery Device industry. This include advancements in Ophthalmic Drug Delivery Device technology, Ophthalmic Drug Delivery Device new entrants, Ophthalmic Drug Delivery Device new investment, and other innovations that are shaping the future of Ophthalmic Drug Delivery Device.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ophthalmic Drug Delivery Device market. It includes factors influencing customer ' purchasing decisions, preferences for Ophthalmic Drug Delivery Device product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ophthalmic Drug Delivery Device market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ophthalmic Drug Delivery Device market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ophthalmic Drug Delivery Device market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ophthalmic Drug Delivery Device industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ophthalmic Drug Delivery Device market.
Market Segmentation:
Ophthalmic Drug Delivery Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Ophthalmic Drug Delivery Device market?
What factors are driving Ophthalmic Drug Delivery Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Drug Delivery Device market opportunities vary by end market size?
How does Ophthalmic Drug Delivery Device break out type, application?
According to our LPI (LP Information) latest study, the global Ophthalmic Drug Delivery Device market size was valued at US$ million in 2023. With growing demand in downstream market, the Ophthalmic Drug Delivery Device is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Ophthalmic Drug Delivery Device market. Ophthalmic Drug Delivery Device are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ophthalmic Drug Delivery Device. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ophthalmic Drug Delivery Device market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Ophthalmic Drug Delivery Device market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ophthalmic Drug Delivery Device market. It may include historical data, market segmentation by Type (e.g., Pre-Filled Syringes, Multidose Eyedroppers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ophthalmic Drug Delivery Device market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ophthalmic Drug Delivery Device market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ophthalmic Drug Delivery Device industry. This include advancements in Ophthalmic Drug Delivery Device technology, Ophthalmic Drug Delivery Device new entrants, Ophthalmic Drug Delivery Device new investment, and other innovations that are shaping the future of Ophthalmic Drug Delivery Device.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ophthalmic Drug Delivery Device market. It includes factors influencing customer ' purchasing decisions, preferences for Ophthalmic Drug Delivery Device product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ophthalmic Drug Delivery Device market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ophthalmic Drug Delivery Device market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ophthalmic Drug Delivery Device market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ophthalmic Drug Delivery Device industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ophthalmic Drug Delivery Device market.
Market Segmentation:
Ophthalmic Drug Delivery Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Pre-Filled Syringes
- Multidose Eyedroppers
- Squeeze Dispenser
- Mist Sprayers
- Add-On Devices
- Contact Lenses
- Others
- Hospitals
- Clinics
- Homecare
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aero Pump GmbH
- AptarGroup
- Bausch Health
- Becton Dickinson & Company
- EyePoint Pharmaceuticals, Inc.
- Gaplast GmbH
- Gerresheimer
- Nemera
- Nipro Corporation
- Ocular Therapeutix
- Owen Mumford
- Silgan Holdings Inc.
- Terumo Corporation
- West Pharmaceutical Services, Inc.
- Kedalion Therapeutics
- Re-Vana Therapeutics
- Mati Therapeutics, Inc.,
- Biocorp Production
- Ocumedic, Inc.
What is the 10-year outlook for the global Ophthalmic Drug Delivery Device market?
What factors are driving Ophthalmic Drug Delivery Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Drug Delivery Device market opportunities vary by end market size?
How does Ophthalmic Drug Delivery Device break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Drug Delivery Device Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ophthalmic Drug Delivery Device by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ophthalmic Drug Delivery Device by Country/Region, 2019, 2023 & 2030
2.2 Ophthalmic Drug Delivery Device Segment by Type
2.2.1 Pre-Filled Syringes
2.2.2 Multidose Eyedroppers
2.2.3 Squeeze Dispenser
2.2.4 Mist Sprayers
2.2.5 Add-On Devices
2.2.6 Contact Lenses
2.2.7 Others
2.3 Ophthalmic Drug Delivery Device Sales by Type
2.3.1 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
2.3.2 Global Ophthalmic Drug Delivery Device Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ophthalmic Drug Delivery Device Sale Price by Type (2019-2024)
2.4 Ophthalmic Drug Delivery Device Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Homecare
2.4.4 Others
2.5 Ophthalmic Drug Delivery Device Sales by Application
2.5.1 Global Ophthalmic Drug Delivery Device Sale Market Share by Application (2019-2024)
2.5.2 Global Ophthalmic Drug Delivery Device Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ophthalmic Drug Delivery Device Sale Price by Application (2019-2024)
3 GLOBAL OPHTHALMIC DRUG DELIVERY DEVICE BY COMPANY
3.1 Global Ophthalmic Drug Delivery Device Breakdown Data by Company
3.1.1 Global Ophthalmic Drug Delivery Device Annual Sales by Company (2019-2024)
3.1.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Company (2019-2024)
3.2 Global Ophthalmic Drug Delivery Device Annual Revenue by Company (2019-2024)
3.2.1 Global Ophthalmic Drug Delivery Device Revenue by Company (2019-2024)
3.2.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Company (2019-2024)
3.3 Global Ophthalmic Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Ophthalmic Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Drug Delivery Device Product Location Distribution
3.4.2 Players Ophthalmic Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Drug Delivery Device Market Size by Geographic Region (2019-2024)
4.1.1 Global Ophthalmic Drug Delivery Device Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ophthalmic Drug Delivery Device Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ophthalmic Drug Delivery Device Market Size by Country/Region (2019-2024)
4.2.1 Global Ophthalmic Drug Delivery Device Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ophthalmic Drug Delivery Device Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ophthalmic Drug Delivery Device Sales Growth
4.4 APAC Ophthalmic Drug Delivery Device Sales Growth
4.5 Europe Ophthalmic Drug Delivery Device Sales Growth
4.6 Middle East & Africa Ophthalmic Drug Delivery Device Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Drug Delivery Device Sales by Country
5.1.1 Americas Ophthalmic Drug Delivery Device Sales by Country (2019-2024)
5.1.2 Americas Ophthalmic Drug Delivery Device Revenue by Country (2019-2024)
5.2 Americas Ophthalmic Drug Delivery Device Sales by Type
5.3 Americas Ophthalmic Drug Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Drug Delivery Device Sales by Region
6.1.1 APAC Ophthalmic Drug Delivery Device Sales by Region (2019-2024)
6.1.2 APAC Ophthalmic Drug Delivery Device Revenue by Region (2019-2024)
6.2 APAC Ophthalmic Drug Delivery Device Sales by Type
6.3 APAC Ophthalmic Drug Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Drug Delivery Device by Country
7.1.1 Europe Ophthalmic Drug Delivery Device Sales by Country (2019-2024)
7.1.2 Europe Ophthalmic Drug Delivery Device Revenue by Country (2019-2024)
7.2 Europe Ophthalmic Drug Delivery Device Sales by Type
7.3 Europe Ophthalmic Drug Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Drug Delivery Device by Country
8.1.1 Middle East & Africa Ophthalmic Drug Delivery Device Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ophthalmic Drug Delivery Device Revenue by Country (2019-2024)
8.2 Middle East & Africa Ophthalmic Drug Delivery Device Sales by Type
8.3 Middle East & Africa Ophthalmic Drug Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Drug Delivery Device
10.3 Manufacturing Process Analysis of Ophthalmic Drug Delivery Device
10.4 Industry Chain Structure of Ophthalmic Drug Delivery Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Drug Delivery Device Distributors
11.3 Ophthalmic Drug Delivery Device Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Ophthalmic Drug Delivery Device Forecast by Region (2025-2030)
12.1.2 Global Ophthalmic Drug Delivery Device Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Drug Delivery Device Forecast by Type
12.7 Global Ophthalmic Drug Delivery Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aero Pump GmbH
13.1.1 Aero Pump GmbH Company Information
13.1.2 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.1.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Aero Pump GmbH Main Business Overview
13.1.5 Aero Pump GmbH Latest Developments
13.2 AptarGroup
13.2.1 AptarGroup Company Information
13.2.2 AptarGroup Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.2.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AptarGroup Main Business Overview
13.2.5 AptarGroup Latest Developments
13.3 Bausch Health
13.3.1 Bausch Health Company Information
13.3.2 Bausch Health Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.3.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bausch Health Main Business Overview
13.3.5 Bausch Health Latest Developments
13.4 Becton Dickinson & Company
13.4.1 Becton Dickinson & Company Company Information
13.4.2 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Becton Dickinson & Company Main Business Overview
13.4.5 Becton Dickinson & Company Latest Developments
13.5 EyePoint Pharmaceuticals, Inc.
13.5.1 EyePoint Pharmaceuticals, Inc. Company Information
13.5.2 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 EyePoint Pharmaceuticals, Inc. Main Business Overview
13.5.5 EyePoint Pharmaceuticals, Inc. Latest Developments
13.6 Gaplast GmbH
13.6.1 Gaplast GmbH Company Information
13.6.2 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.6.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Gaplast GmbH Main Business Overview
13.6.5 Gaplast GmbH Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.7.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
13.8 Nemera
13.8.1 Nemera Company Information
13.8.2 Nemera Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.8.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Nemera Main Business Overview
13.8.5 Nemera Latest Developments
13.9 Nipro Corporation
13.9.1 Nipro Corporation Company Information
13.9.2 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.9.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Nipro Corporation Main Business Overview
13.9.5 Nipro Corporation Latest Developments
13.10 Ocular Therapeutix
13.10.1 Ocular Therapeutix Company Information
13.10.2 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.10.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ocular Therapeutix Main Business Overview
13.10.5 Ocular Therapeutix Latest Developments
13.11 Owen Mumford
13.11.1 Owen Mumford Company Information
13.11.2 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.11.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Owen Mumford Main Business Overview
13.11.5 Owen Mumford Latest Developments
13.12 Silgan Holdings Inc.
13.12.1 Silgan Holdings Inc. Company Information
13.12.2 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Silgan Holdings Inc. Main Business Overview
13.12.5 Silgan Holdings Inc. Latest Developments
13.13 Terumo Corporation
13.13.1 Terumo Corporation Company Information
13.13.2 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.13.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Terumo Corporation Main Business Overview
13.13.5 Terumo Corporation Latest Developments
13.14 West Pharmaceutical Services, Inc.
13.14.1 West Pharmaceutical Services, Inc. Company Information
13.14.2 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 West Pharmaceutical Services, Inc. Main Business Overview
13.14.5 West Pharmaceutical Services, Inc. Latest Developments
13.15 Kedalion Therapeutics
13.15.1 Kedalion Therapeutics Company Information
13.15.2 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Kedalion Therapeutics Main Business Overview
13.15.5 Kedalion Therapeutics Latest Developments
13.16 Re-Vana Therapeutics
13.16.1 Re-Vana Therapeutics Company Information
13.16.2 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Re-Vana Therapeutics Main Business Overview
13.16.5 Re-Vana Therapeutics Latest Developments
13.17 Mati Therapeutics, Inc.,
13.17.1 Mati Therapeutics, Inc., Company Information
13.17.2 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Mati Therapeutics, Inc., Main Business Overview
13.17.5 Mati Therapeutics, Inc., Latest Developments
13.18 Biocorp Production
13.18.1 Biocorp Production Company Information
13.18.2 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.18.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Biocorp Production Main Business Overview
13.18.5 Biocorp Production Latest Developments
13.19 Ocumedic, Inc.
13.19.1 Ocumedic, Inc. Company Information
13.19.2 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Ocumedic, Inc. Main Business Overview
13.19.5 Ocumedic, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Drug Delivery Device Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ophthalmic Drug Delivery Device by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ophthalmic Drug Delivery Device by Country/Region, 2019, 2023 & 2030
2.2 Ophthalmic Drug Delivery Device Segment by Type
2.2.1 Pre-Filled Syringes
2.2.2 Multidose Eyedroppers
2.2.3 Squeeze Dispenser
2.2.4 Mist Sprayers
2.2.5 Add-On Devices
2.2.6 Contact Lenses
2.2.7 Others
2.3 Ophthalmic Drug Delivery Device Sales by Type
2.3.1 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
2.3.2 Global Ophthalmic Drug Delivery Device Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ophthalmic Drug Delivery Device Sale Price by Type (2019-2024)
2.4 Ophthalmic Drug Delivery Device Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Homecare
2.4.4 Others
2.5 Ophthalmic Drug Delivery Device Sales by Application
2.5.1 Global Ophthalmic Drug Delivery Device Sale Market Share by Application (2019-2024)
2.5.2 Global Ophthalmic Drug Delivery Device Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ophthalmic Drug Delivery Device Sale Price by Application (2019-2024)
3 GLOBAL OPHTHALMIC DRUG DELIVERY DEVICE BY COMPANY
3.1 Global Ophthalmic Drug Delivery Device Breakdown Data by Company
3.1.1 Global Ophthalmic Drug Delivery Device Annual Sales by Company (2019-2024)
3.1.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Company (2019-2024)
3.2 Global Ophthalmic Drug Delivery Device Annual Revenue by Company (2019-2024)
3.2.1 Global Ophthalmic Drug Delivery Device Revenue by Company (2019-2024)
3.2.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Company (2019-2024)
3.3 Global Ophthalmic Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Ophthalmic Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Drug Delivery Device Product Location Distribution
3.4.2 Players Ophthalmic Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Drug Delivery Device Market Size by Geographic Region (2019-2024)
4.1.1 Global Ophthalmic Drug Delivery Device Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ophthalmic Drug Delivery Device Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ophthalmic Drug Delivery Device Market Size by Country/Region (2019-2024)
4.2.1 Global Ophthalmic Drug Delivery Device Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ophthalmic Drug Delivery Device Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ophthalmic Drug Delivery Device Sales Growth
4.4 APAC Ophthalmic Drug Delivery Device Sales Growth
4.5 Europe Ophthalmic Drug Delivery Device Sales Growth
4.6 Middle East & Africa Ophthalmic Drug Delivery Device Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Drug Delivery Device Sales by Country
5.1.1 Americas Ophthalmic Drug Delivery Device Sales by Country (2019-2024)
5.1.2 Americas Ophthalmic Drug Delivery Device Revenue by Country (2019-2024)
5.2 Americas Ophthalmic Drug Delivery Device Sales by Type
5.3 Americas Ophthalmic Drug Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Drug Delivery Device Sales by Region
6.1.1 APAC Ophthalmic Drug Delivery Device Sales by Region (2019-2024)
6.1.2 APAC Ophthalmic Drug Delivery Device Revenue by Region (2019-2024)
6.2 APAC Ophthalmic Drug Delivery Device Sales by Type
6.3 APAC Ophthalmic Drug Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Drug Delivery Device by Country
7.1.1 Europe Ophthalmic Drug Delivery Device Sales by Country (2019-2024)
7.1.2 Europe Ophthalmic Drug Delivery Device Revenue by Country (2019-2024)
7.2 Europe Ophthalmic Drug Delivery Device Sales by Type
7.3 Europe Ophthalmic Drug Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Drug Delivery Device by Country
8.1.1 Middle East & Africa Ophthalmic Drug Delivery Device Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ophthalmic Drug Delivery Device Revenue by Country (2019-2024)
8.2 Middle East & Africa Ophthalmic Drug Delivery Device Sales by Type
8.3 Middle East & Africa Ophthalmic Drug Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Drug Delivery Device
10.3 Manufacturing Process Analysis of Ophthalmic Drug Delivery Device
10.4 Industry Chain Structure of Ophthalmic Drug Delivery Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Drug Delivery Device Distributors
11.3 Ophthalmic Drug Delivery Device Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Ophthalmic Drug Delivery Device Forecast by Region (2025-2030)
12.1.2 Global Ophthalmic Drug Delivery Device Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Drug Delivery Device Forecast by Type
12.7 Global Ophthalmic Drug Delivery Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aero Pump GmbH
13.1.1 Aero Pump GmbH Company Information
13.1.2 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.1.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Aero Pump GmbH Main Business Overview
13.1.5 Aero Pump GmbH Latest Developments
13.2 AptarGroup
13.2.1 AptarGroup Company Information
13.2.2 AptarGroup Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.2.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AptarGroup Main Business Overview
13.2.5 AptarGroup Latest Developments
13.3 Bausch Health
13.3.1 Bausch Health Company Information
13.3.2 Bausch Health Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.3.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bausch Health Main Business Overview
13.3.5 Bausch Health Latest Developments
13.4 Becton Dickinson & Company
13.4.1 Becton Dickinson & Company Company Information
13.4.2 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Becton Dickinson & Company Main Business Overview
13.4.5 Becton Dickinson & Company Latest Developments
13.5 EyePoint Pharmaceuticals, Inc.
13.5.1 EyePoint Pharmaceuticals, Inc. Company Information
13.5.2 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 EyePoint Pharmaceuticals, Inc. Main Business Overview
13.5.5 EyePoint Pharmaceuticals, Inc. Latest Developments
13.6 Gaplast GmbH
13.6.1 Gaplast GmbH Company Information
13.6.2 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.6.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Gaplast GmbH Main Business Overview
13.6.5 Gaplast GmbH Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.7.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
13.8 Nemera
13.8.1 Nemera Company Information
13.8.2 Nemera Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.8.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Nemera Main Business Overview
13.8.5 Nemera Latest Developments
13.9 Nipro Corporation
13.9.1 Nipro Corporation Company Information
13.9.2 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.9.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Nipro Corporation Main Business Overview
13.9.5 Nipro Corporation Latest Developments
13.10 Ocular Therapeutix
13.10.1 Ocular Therapeutix Company Information
13.10.2 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.10.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ocular Therapeutix Main Business Overview
13.10.5 Ocular Therapeutix Latest Developments
13.11 Owen Mumford
13.11.1 Owen Mumford Company Information
13.11.2 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.11.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Owen Mumford Main Business Overview
13.11.5 Owen Mumford Latest Developments
13.12 Silgan Holdings Inc.
13.12.1 Silgan Holdings Inc. Company Information
13.12.2 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Silgan Holdings Inc. Main Business Overview
13.12.5 Silgan Holdings Inc. Latest Developments
13.13 Terumo Corporation
13.13.1 Terumo Corporation Company Information
13.13.2 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.13.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Terumo Corporation Main Business Overview
13.13.5 Terumo Corporation Latest Developments
13.14 West Pharmaceutical Services, Inc.
13.14.1 West Pharmaceutical Services, Inc. Company Information
13.14.2 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 West Pharmaceutical Services, Inc. Main Business Overview
13.14.5 West Pharmaceutical Services, Inc. Latest Developments
13.15 Kedalion Therapeutics
13.15.1 Kedalion Therapeutics Company Information
13.15.2 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Kedalion Therapeutics Main Business Overview
13.15.5 Kedalion Therapeutics Latest Developments
13.16 Re-Vana Therapeutics
13.16.1 Re-Vana Therapeutics Company Information
13.16.2 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Re-Vana Therapeutics Main Business Overview
13.16.5 Re-Vana Therapeutics Latest Developments
13.17 Mati Therapeutics, Inc.,
13.17.1 Mati Therapeutics, Inc., Company Information
13.17.2 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Mati Therapeutics, Inc., Main Business Overview
13.17.5 Mati Therapeutics, Inc., Latest Developments
13.18 Biocorp Production
13.18.1 Biocorp Production Company Information
13.18.2 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.18.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Biocorp Production Main Business Overview
13.18.5 Biocorp Production Latest Developments
13.19 Ocumedic, Inc.
13.19.1 Ocumedic, Inc. Company Information
13.19.2 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
13.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Ocumedic, Inc. Main Business Overview
13.19.5 Ocumedic, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ophthalmic Drug Delivery Device Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ophthalmic Drug Delivery Device Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pre-Filled Syringes
Table 4. Major Players of Multidose Eyedroppers
Table 5. Major Players of Squeeze Dispenser
Table 6. Major Players of Mist Sprayers
Table 7. Major Players of Add-On Devices
Table 8. Major Players of Contact Lenses
Table 9. Major Players of Others
Table 10. Global Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 11. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Table 12. Global Ophthalmic Drug Delivery Device Revenue by Type (2019-2024) & ($ million)
Table 13. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2019-2024)
Table 14. Global Ophthalmic Drug Delivery Device Sale Price by Type (2019-2024) & (US$/Unit)
Table 15. Global Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 16. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Table 17. Global Ophthalmic Drug Delivery Device Revenue by Application (2019-2024)
Table 18. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2019-2024)
Table 19. Global Ophthalmic Drug Delivery Device Sale Price by Application (2019-2024) & (US$/Unit)
Table 20. Global Ophthalmic Drug Delivery Device Sales by Company (2019-2024) & (K Units)
Table 21. Global Ophthalmic Drug Delivery Device Sales Market Share by Company (2019-2024)
Table 22. Global Ophthalmic Drug Delivery Device Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Ophthalmic Drug Delivery Device Revenue Market Share by Company (2019-2024)
Table 24. Global Ophthalmic Drug Delivery Device Sale Price by Company (2019-2024) & (US$/Unit)
Table 25. Key Manufacturers Ophthalmic Drug Delivery Device Producing Area Distribution and Sales Area
Table 26. Players Ophthalmic Drug Delivery Device Products Offered
Table 27. Ophthalmic Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Ophthalmic Drug Delivery Device Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global Ophthalmic Drug Delivery Device Sales Market Share Geographic Region (2019-2024)
Table 32. Global Ophthalmic Drug Delivery Device Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Ophthalmic Drug Delivery Device Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Ophthalmic Drug Delivery Device Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global Ophthalmic Drug Delivery Device Sales Market Share by Country/Region (2019-2024)
Table 36. Global Ophthalmic Drug Delivery Device Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Ophthalmic Drug Delivery Device Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Ophthalmic Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 39. Americas Ophthalmic Drug Delivery Device Sales Market Share by Country (2019-2024)
Table 40. Americas Ophthalmic Drug Delivery Device Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Ophthalmic Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 42. Americas Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 43. Americas Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 44. APAC Ophthalmic Drug Delivery Device Sales by Region (2019-2024) & (K Units)
Table 45. APAC Ophthalmic Drug Delivery Device Sales Market Share by Region (2019-2024)
Table 46. APAC Ophthalmic Drug Delivery Device Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Ophthalmic Drug Delivery Device Revenue Market Share by Region (2019-2024)
Table 48. APAC Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 49. APAC Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 50. Europe Ophthalmic Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 51. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country (2019-2024)
Table 52. Europe Ophthalmic Drug Delivery Device Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Ophthalmic Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 54. Europe Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 55. Europe Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 56. Middle East & Africa Ophthalmic Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 57. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Ophthalmic Drug Delivery Device Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Ophthalmic Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 61. Middle East & Africa Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Ophthalmic Drug Delivery Device
Table 63. Key Market Challenges & Risks of Ophthalmic Drug Delivery Device
Table 64. Key Industry Trends of Ophthalmic Drug Delivery Device
Table 65. Ophthalmic Drug Delivery Device Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Ophthalmic Drug Delivery Device Distributors List
Table 68. Ophthalmic Drug Delivery Device Customer List
Table 69. Global Ophthalmic Drug Delivery Device Sales Forecast by Region (2025-2030) & (K Units)
Table 70. Global Ophthalmic Drug Delivery Device Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Ophthalmic Drug Delivery Device Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Americas Ophthalmic Drug Delivery Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Ophthalmic Drug Delivery Device Sales Forecast by Region (2025-2030) & (K Units)
Table 74. APAC Ophthalmic Drug Delivery Device Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Ophthalmic Drug Delivery Device Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Ophthalmic Drug Delivery Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Ophthalmic Drug Delivery Device Sales Forecast by Country (2025-2030) & (K Units)
Table 78. Middle East & Africa Ophthalmic Drug Delivery Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Ophthalmic Drug Delivery Device Sales Forecast by Type (2025-2030) & (K Units)
Table 80. Global Ophthalmic Drug Delivery Device Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Ophthalmic Drug Delivery Device Sales Forecast by Application (2025-2030) & (K Units)
Table 82. Global Ophthalmic Drug Delivery Device Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. Aero Pump GmbH Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 85. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Aero Pump GmbH Main Business
Table 87. Aero Pump GmbH Latest Developments
Table 88. AptarGroup Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 89. AptarGroup Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 90. AptarGroup Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. AptarGroup Main Business
Table 92. AptarGroup Latest Developments
Table 93. Bausch Health Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Bausch Health Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 95. Bausch Health Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Bausch Health Main Business
Table 97. Bausch Health Latest Developments
Table 98. Becton Dickinson & Company Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 100. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Becton Dickinson & Company Main Business
Table 102. Becton Dickinson & Company Latest Developments
Table 103. EyePoint Pharmaceuticals, Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 104. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 105. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. EyePoint Pharmaceuticals, Inc. Main Business
Table 107. EyePoint Pharmaceuticals, Inc. Latest Developments
Table 108. Gaplast GmbH Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 110. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Gaplast GmbH Main Business
Table 112. Gaplast GmbH Latest Developments
Table 113. Gerresheimer Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Gerresheimer Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 115. Gerresheimer Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Gerresheimer Main Business
Table 117. Gerresheimer Latest Developments
Table 118. Nemera Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Nemera Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 120. Nemera Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Nemera Main Business
Table 122. Nemera Latest Developments
Table 123. Nipro Corporation Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 125. Nipro Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Nipro Corporation Main Business
Table 127. Nipro Corporation Latest Developments
Table 128. Ocular Therapeutix Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 130. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Ocular Therapeutix Main Business
Table 132. Ocular Therapeutix Latest Developments
Table 133. Owen Mumford Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 134. Owen Mumford Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 135. Owen Mumford Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Owen Mumford Main Business
Table 137. Owen Mumford Latest Developments
Table 138. Silgan Holdings Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 140. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Silgan Holdings Inc. Main Business
Table 142. Silgan Holdings Inc. Latest Developments
Table 143. Terumo Corporation Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 145. Terumo Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Terumo Corporation Main Business
Table 147. Terumo Corporation Latest Developments
Table 148. West Pharmaceutical Services, Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 149. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 150. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. West Pharmaceutical Services, Inc. Main Business
Table 152. West Pharmaceutical Services, Inc. Latest Developments
Table 153. Kedalion Therapeutics Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 154. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 155. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Kedalion Therapeutics Main Business
Table 157. Kedalion Therapeutics Latest Developments
Table 158. Re-Vana Therapeutics Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 159. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 160. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 161. Re-Vana Therapeutics Main Business
Table 162. Re-Vana Therapeutics Latest Developments
Table 163. Mati Therapeutics, Inc., Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 164. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 165. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 166. Mati Therapeutics, Inc., Main Business
Table 167. Mati Therapeutics, Inc., Latest Developments
Table 168. Biocorp Production Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 169. Biocorp Production Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 170. Biocorp Production Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 171. Biocorp Production Main Business
Table 172. Biocorp Production Latest Developments
Table 173. Ocumedic, Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 174. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 175. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 176. Ocumedic, Inc. Main Business
Table 177. Ocumedic, Inc. Latest Developments
Table 1. Ophthalmic Drug Delivery Device Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ophthalmic Drug Delivery Device Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pre-Filled Syringes
Table 4. Major Players of Multidose Eyedroppers
Table 5. Major Players of Squeeze Dispenser
Table 6. Major Players of Mist Sprayers
Table 7. Major Players of Add-On Devices
Table 8. Major Players of Contact Lenses
Table 9. Major Players of Others
Table 10. Global Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 11. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Table 12. Global Ophthalmic Drug Delivery Device Revenue by Type (2019-2024) & ($ million)
Table 13. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2019-2024)
Table 14. Global Ophthalmic Drug Delivery Device Sale Price by Type (2019-2024) & (US$/Unit)
Table 15. Global Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 16. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Table 17. Global Ophthalmic Drug Delivery Device Revenue by Application (2019-2024)
Table 18. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2019-2024)
Table 19. Global Ophthalmic Drug Delivery Device Sale Price by Application (2019-2024) & (US$/Unit)
Table 20. Global Ophthalmic Drug Delivery Device Sales by Company (2019-2024) & (K Units)
Table 21. Global Ophthalmic Drug Delivery Device Sales Market Share by Company (2019-2024)
Table 22. Global Ophthalmic Drug Delivery Device Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Ophthalmic Drug Delivery Device Revenue Market Share by Company (2019-2024)
Table 24. Global Ophthalmic Drug Delivery Device Sale Price by Company (2019-2024) & (US$/Unit)
Table 25. Key Manufacturers Ophthalmic Drug Delivery Device Producing Area Distribution and Sales Area
Table 26. Players Ophthalmic Drug Delivery Device Products Offered
Table 27. Ophthalmic Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Ophthalmic Drug Delivery Device Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global Ophthalmic Drug Delivery Device Sales Market Share Geographic Region (2019-2024)
Table 32. Global Ophthalmic Drug Delivery Device Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Ophthalmic Drug Delivery Device Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Ophthalmic Drug Delivery Device Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global Ophthalmic Drug Delivery Device Sales Market Share by Country/Region (2019-2024)
Table 36. Global Ophthalmic Drug Delivery Device Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Ophthalmic Drug Delivery Device Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Ophthalmic Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 39. Americas Ophthalmic Drug Delivery Device Sales Market Share by Country (2019-2024)
Table 40. Americas Ophthalmic Drug Delivery Device Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Ophthalmic Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 42. Americas Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 43. Americas Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 44. APAC Ophthalmic Drug Delivery Device Sales by Region (2019-2024) & (K Units)
Table 45. APAC Ophthalmic Drug Delivery Device Sales Market Share by Region (2019-2024)
Table 46. APAC Ophthalmic Drug Delivery Device Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Ophthalmic Drug Delivery Device Revenue Market Share by Region (2019-2024)
Table 48. APAC Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 49. APAC Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 50. Europe Ophthalmic Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 51. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country (2019-2024)
Table 52. Europe Ophthalmic Drug Delivery Device Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Ophthalmic Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 54. Europe Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 55. Europe Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 56. Middle East & Africa Ophthalmic Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 57. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Ophthalmic Drug Delivery Device Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Ophthalmic Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Ophthalmic Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 61. Middle East & Africa Ophthalmic Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Ophthalmic Drug Delivery Device
Table 63. Key Market Challenges & Risks of Ophthalmic Drug Delivery Device
Table 64. Key Industry Trends of Ophthalmic Drug Delivery Device
Table 65. Ophthalmic Drug Delivery Device Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Ophthalmic Drug Delivery Device Distributors List
Table 68. Ophthalmic Drug Delivery Device Customer List
Table 69. Global Ophthalmic Drug Delivery Device Sales Forecast by Region (2025-2030) & (K Units)
Table 70. Global Ophthalmic Drug Delivery Device Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Ophthalmic Drug Delivery Device Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Americas Ophthalmic Drug Delivery Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Ophthalmic Drug Delivery Device Sales Forecast by Region (2025-2030) & (K Units)
Table 74. APAC Ophthalmic Drug Delivery Device Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Ophthalmic Drug Delivery Device Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Ophthalmic Drug Delivery Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Ophthalmic Drug Delivery Device Sales Forecast by Country (2025-2030) & (K Units)
Table 78. Middle East & Africa Ophthalmic Drug Delivery Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Ophthalmic Drug Delivery Device Sales Forecast by Type (2025-2030) & (K Units)
Table 80. Global Ophthalmic Drug Delivery Device Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Ophthalmic Drug Delivery Device Sales Forecast by Application (2025-2030) & (K Units)
Table 82. Global Ophthalmic Drug Delivery Device Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. Aero Pump GmbH Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 85. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Aero Pump GmbH Main Business
Table 87. Aero Pump GmbH Latest Developments
Table 88. AptarGroup Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 89. AptarGroup Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 90. AptarGroup Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. AptarGroup Main Business
Table 92. AptarGroup Latest Developments
Table 93. Bausch Health Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Bausch Health Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 95. Bausch Health Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Bausch Health Main Business
Table 97. Bausch Health Latest Developments
Table 98. Becton Dickinson & Company Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 100. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Becton Dickinson & Company Main Business
Table 102. Becton Dickinson & Company Latest Developments
Table 103. EyePoint Pharmaceuticals, Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 104. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 105. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. EyePoint Pharmaceuticals, Inc. Main Business
Table 107. EyePoint Pharmaceuticals, Inc. Latest Developments
Table 108. Gaplast GmbH Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 110. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Gaplast GmbH Main Business
Table 112. Gaplast GmbH Latest Developments
Table 113. Gerresheimer Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Gerresheimer Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 115. Gerresheimer Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Gerresheimer Main Business
Table 117. Gerresheimer Latest Developments
Table 118. Nemera Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Nemera Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 120. Nemera Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Nemera Main Business
Table 122. Nemera Latest Developments
Table 123. Nipro Corporation Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 125. Nipro Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Nipro Corporation Main Business
Table 127. Nipro Corporation Latest Developments
Table 128. Ocular Therapeutix Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 130. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Ocular Therapeutix Main Business
Table 132. Ocular Therapeutix Latest Developments
Table 133. Owen Mumford Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 134. Owen Mumford Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 135. Owen Mumford Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Owen Mumford Main Business
Table 137. Owen Mumford Latest Developments
Table 138. Silgan Holdings Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 140. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Silgan Holdings Inc. Main Business
Table 142. Silgan Holdings Inc. Latest Developments
Table 143. Terumo Corporation Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 145. Terumo Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Terumo Corporation Main Business
Table 147. Terumo Corporation Latest Developments
Table 148. West Pharmaceutical Services, Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 149. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 150. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. West Pharmaceutical Services, Inc. Main Business
Table 152. West Pharmaceutical Services, Inc. Latest Developments
Table 153. Kedalion Therapeutics Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 154. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 155. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Kedalion Therapeutics Main Business
Table 157. Kedalion Therapeutics Latest Developments
Table 158. Re-Vana Therapeutics Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 159. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 160. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 161. Re-Vana Therapeutics Main Business
Table 162. Re-Vana Therapeutics Latest Developments
Table 163. Mati Therapeutics, Inc., Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 164. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 165. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 166. Mati Therapeutics, Inc., Main Business
Table 167. Mati Therapeutics, Inc., Latest Developments
Table 168. Biocorp Production Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 169. Biocorp Production Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 170. Biocorp Production Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 171. Biocorp Production Main Business
Table 172. Biocorp Production Latest Developments
Table 173. Ocumedic, Inc. Basic Information, Ophthalmic Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 174. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolios and Specifications
Table 175. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 176. Ocumedic, Inc. Main Business
Table 177. Ocumedic, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ophthalmic Drug Delivery Device
Figure 2. Ophthalmic Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Drug Delivery Device Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Ophthalmic Drug Delivery Device Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Ophthalmic Drug Delivery Device Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pre-Filled Syringes
Figure 10. Product Picture of Multidose Eyedroppers
Figure 11. Product Picture of Squeeze Dispenser
Figure 12. Product Picture of Mist Sprayers
Figure 13. Product Picture of Add-On Devices
Figure 14. Product Picture of Contact Lenses
Figure 15. Product Picture of Others
Figure 16. Global Ophthalmic Drug Delivery Device Sales Market Share by Type in 2023
Figure 17. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2019-2024)
Figure 18. Ophthalmic Drug Delivery Device Consumed in Hospitals
Figure 19. Global Ophthalmic Drug Delivery Device Market: Hospitals (2019-2024) & (K Units)
Figure 20. Ophthalmic Drug Delivery Device Consumed in Clinics
Figure 21. Global Ophthalmic Drug Delivery Device Market: Clinics (2019-2024) & (K Units)
Figure 22. Ophthalmic Drug Delivery Device Consumed in Homecare
Figure 23. Global Ophthalmic Drug Delivery Device Market: Homecare (2019-2024) & (K Units)
Figure 24. Ophthalmic Drug Delivery Device Consumed in Others
Figure 25. Global Ophthalmic Drug Delivery Device Market: Others (2019-2024) & (K Units)
Figure 26. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2023)
Figure 27. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application in 2023
Figure 28. Ophthalmic Drug Delivery Device Sales Market by Company in 2023 (K Units)
Figure 29. Global Ophthalmic Drug Delivery Device Sales Market Share by Company in 2023
Figure 30. Ophthalmic Drug Delivery Device Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Ophthalmic Drug Delivery Device Revenue Market Share by Company in 2023
Figure 32. Global Ophthalmic Drug Delivery Device Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Ophthalmic Drug Delivery Device Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 35. Americas Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 36. APAC Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 37. APAC Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 38. Europe Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 39. Europe Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 42. Americas Ophthalmic Drug Delivery Device Sales Market Share by Country in 2023
Figure 43. Americas Ophthalmic Drug Delivery Device Revenue Market Share by Country in 2023
Figure 44. Americas Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 45. Americas Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 46. United States Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Ophthalmic Drug Delivery Device Sales Market Share by Region in 2023
Figure 51. APAC Ophthalmic Drug Delivery Device Revenue Market Share by Regions in 2023
Figure 52. APAC Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 53. APAC Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 54. China Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country in 2023
Figure 62. Europe Ophthalmic Drug Delivery Device Revenue Market Share by Country in 2023
Figure 63. Europe Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 64. Europe Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 65. Germany Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Ophthalmic Drug Delivery Device Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 74. Egypt Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Ophthalmic Drug Delivery Device in 2023
Figure 80. Manufacturing Process Analysis of Ophthalmic Drug Delivery Device
Figure 81. Industry Chain Structure of Ophthalmic Drug Delivery Device
Figure 82. Channels of Distribution
Figure 83. Global Ophthalmic Drug Delivery Device Sales Market Forecast by Region (2025-2030)
Figure 84. Global Ophthalmic Drug Delivery Device Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Ophthalmic Drug Delivery Device Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Ophthalmic Drug Delivery Device Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Ophthalmic Drug Delivery Device Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Ophthalmic Drug Delivery Device Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Ophthalmic Drug Delivery Device
Figure 2. Ophthalmic Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Drug Delivery Device Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Ophthalmic Drug Delivery Device Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Ophthalmic Drug Delivery Device Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pre-Filled Syringes
Figure 10. Product Picture of Multidose Eyedroppers
Figure 11. Product Picture of Squeeze Dispenser
Figure 12. Product Picture of Mist Sprayers
Figure 13. Product Picture of Add-On Devices
Figure 14. Product Picture of Contact Lenses
Figure 15. Product Picture of Others
Figure 16. Global Ophthalmic Drug Delivery Device Sales Market Share by Type in 2023
Figure 17. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2019-2024)
Figure 18. Ophthalmic Drug Delivery Device Consumed in Hospitals
Figure 19. Global Ophthalmic Drug Delivery Device Market: Hospitals (2019-2024) & (K Units)
Figure 20. Ophthalmic Drug Delivery Device Consumed in Clinics
Figure 21. Global Ophthalmic Drug Delivery Device Market: Clinics (2019-2024) & (K Units)
Figure 22. Ophthalmic Drug Delivery Device Consumed in Homecare
Figure 23. Global Ophthalmic Drug Delivery Device Market: Homecare (2019-2024) & (K Units)
Figure 24. Ophthalmic Drug Delivery Device Consumed in Others
Figure 25. Global Ophthalmic Drug Delivery Device Market: Others (2019-2024) & (K Units)
Figure 26. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2023)
Figure 27. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application in 2023
Figure 28. Ophthalmic Drug Delivery Device Sales Market by Company in 2023 (K Units)
Figure 29. Global Ophthalmic Drug Delivery Device Sales Market Share by Company in 2023
Figure 30. Ophthalmic Drug Delivery Device Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Ophthalmic Drug Delivery Device Revenue Market Share by Company in 2023
Figure 32. Global Ophthalmic Drug Delivery Device Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Ophthalmic Drug Delivery Device Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 35. Americas Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 36. APAC Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 37. APAC Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 38. Europe Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 39. Europe Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Ophthalmic Drug Delivery Device Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Ophthalmic Drug Delivery Device Revenue 2019-2024 ($ Millions)
Figure 42. Americas Ophthalmic Drug Delivery Device Sales Market Share by Country in 2023
Figure 43. Americas Ophthalmic Drug Delivery Device Revenue Market Share by Country in 2023
Figure 44. Americas Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 45. Americas Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 46. United States Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Ophthalmic Drug Delivery Device Sales Market Share by Region in 2023
Figure 51. APAC Ophthalmic Drug Delivery Device Revenue Market Share by Regions in 2023
Figure 52. APAC Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 53. APAC Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 54. China Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country in 2023
Figure 62. Europe Ophthalmic Drug Delivery Device Revenue Market Share by Country in 2023
Figure 63. Europe Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 64. Europe Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 65. Germany Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Ophthalmic Drug Delivery Device Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Ophthalmic Drug Delivery Device Sales Market Share by Application (2019-2024)
Figure 74. Egypt Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Ophthalmic Drug Delivery Device Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Ophthalmic Drug Delivery Device in 2023
Figure 80. Manufacturing Process Analysis of Ophthalmic Drug Delivery Device
Figure 81. Industry Chain Structure of Ophthalmic Drug Delivery Device
Figure 82. Channels of Distribution
Figure 83. Global Ophthalmic Drug Delivery Device Sales Market Forecast by Region (2025-2030)
Figure 84. Global Ophthalmic Drug Delivery Device Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Ophthalmic Drug Delivery Device Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Ophthalmic Drug Delivery Device Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Ophthalmic Drug Delivery Device Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Ophthalmic Drug Delivery Device Revenue Market Share Forecast by Application (2025-2030)
